We are a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic.
Who We Are
Cyrus is based in Seattle, WA and financed by leading US and Asian Biotech and Tech investors including Orbimed, Trinity Ventures, Springrock, Agent Capital, iSelect, Yard Ventures, WRF and Alexandria. We have worked with over 120 industry customers and partners, including Genentech, Janssen, and Selecta Bio
INTERESTED IN
PARTNERING WITH US ON
PROTEIN THERAPEUTICS?